Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease [NA]

View source ↗

Summary

A clinical trial evaluating Efferon LPS for Crohn's disease and ulcerative colitis is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Efferon LPS

Snippet

Sponsor: Efferon JSC | Conditions: Crohn Disease, Ulcerative Colitis | NA | Status: NOT_YET_RECRUITING